TLDR Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.
The study investigated the role of Bcl-2 in hair growth and keratinocyte apoptosis using transgenic mice overexpressing human Bcl-2. These K14/Bcl-2 mice exhibited significantly fewer UVB-induced apoptotic keratinocytes compared to wild-type mice, indicating protection from UVB-induced apoptosis. However, the overexpression of Bcl-2 did not affect neonatal hair follicle morphogenesis or the onset of the first wave of hair follicle regression (catagen). Instead, it accelerated spontaneous catagen progression and promoted follicular dystrophy during chemotherapy-induced alopecia. Thus, while Bcl-2 overexpression protected against UVB-induced apoptosis, it unexpectedly enhanced catagen- and chemotherapy-associated keratinocyte apoptosis.
37 citations
,
July 1999 in “The EMBO Journal” Overexpression of certain genes can shorten hair by disrupting the hair-growth cycle.
109 citations
,
December 1998 in “The Journal of Dermatology” Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.
140 citations
,
December 1998 in “Journal of Investigative Dermatology” Apoptosis in hair follicles varies by growth phase, with TGF-β possibly starting the catagen phase.
148 citations
,
October 1997 in “Journal of Investigative Dermatology” 64 citations
,
January 1995 in “Cells Tissues Organs” Merkel cells develop independently of nerves and are linked to specific hair follicles in mice.
122 citations
,
July 1994 in “Journal of Investigative Dermatology”
36 citations
,
April 1994 in “PubMed” Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.
253 citations
,
March 1994 in “Developmental dynamics” Apoptosis is essential for human skin development and forming a functional epidermis.
19 citations
,
February 2013 in “Archives of Dermatological Research” 30 citations
,
June 1993 in “The Journal of Cell Biology” The oncoprotein causes abnormal hair growth without increasing skin cancer risk.
7 citations
,
March 1993 in “International Journal of Oncology” Basal cell carcinoma shows keratin patterns similar to hair follicle structures.
128 citations
,
February 1992 in “British Journal of Dermatology” Basal cell carcinomas likely originate from hair follicle cells or stem cells.
198 citations
,
November 1989 in “The Journal of Cell Biology” Keratin K14 expression varies between hair follicles and epidermis, affecting cell differentiation.